Abeona Therapeutics Inc. Common Stock
Symbol: ABEO (NASDAQ)
0.00
▼ (-100.00%) -6.530
Company Description:
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $6.53
- Yesterday High: $6.95
- Yesterday Low: $6.53
- Yesterday Volume: 961.19K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Abeona Therapeutics Inc. Common Stock
- Website: https://www.abeonatherapeutics.com
- Listed Date: 1980-09-19
- Location: CLEVELAND, OH
- Market Status: Active
- CIK Number: 0000318306
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $334.85M
- Round Lot: 100
- Outstanding Shares: 51.28M
- Asset Type: CS
RECENT FILINGS FOR ABEO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 144 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-07-22 | 4 | View |
| 2025-07-22 | 144 | View |
| 2025-07-18 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-09 | 144 | View |
| 2025-07-09 | 144 | View |
| 2025-07-09 | 144 | View |
Latest News on ABEO